Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study

BACKGROUND: Curative-intent therapies for hepatocellular carcinoma (HCC) include radiofrequency ablation (RFA), liver resection (LR), and liver transplantation (LT). Controversy exists in treatment selection for early-stage tumours. We sought to evaluate the oncologic outcomes of patients who receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanics, T., Rajendran, L., Abreu, P.A., Claasen, M.P.A.W., Shwaartz, C., Patel, M.S., Choi, W.J., Doyle, A., Muaddi, H., McGilvray, I.D., Selzner, M., Beecroft, R., Kachura, J., Bhat, M., Selzner, N., Ghanekar, A., Cattral, M., Sayed, B., Reichman, T., Lilly, L., Sapisochin, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142643/
https://www.ncbi.nlm.nih.gov/pubmed/35637985
http://dx.doi.org/10.1016/j.amsu.2022.103645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142643/
https://www.ncbi.nlm.nih.gov/pubmed/35637985
http://dx.doi.org/10.1016/j.amsu.2022.103645

Ejemplares similares